Marex CEO awarded 77,843 shares under incentive plan
Marex Group Ltd (MRX) reported that Chief Executive Officer and director Ian T. Lowitt acquired 77,843 Ordinary Shares on August 19, 2026 via a grant/award under the 2022 Annual Long Term Incentive Plan at a stated price of $0.00 per share.
Sentiment and the balance of points
Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.
Rhea-AI Filing Summary
Marex Group Ltd (MRX) reported that Chief Executive Officer and director Ian T. Lowitt acquired 77,843 Ordinary Shares on August 19, 2026 via a grant/award under the 2022 Annual Long Term Incentive Plan at a stated price of $0.00 per share. The Remuneration Committee determined that performance conditions tied to return on equity and growth in adjusted operating profit before tax had been met, so these shares are vesting subject to continued service until September 6, 2026. Following this transaction, Lowitt holds 2,872,059 Ordinary Shares directly, including 194,411 shares underlying deferred bonus plan awards.
Insider Trade Summary
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| Grant/Award | Ordinary Shares F1, F2 | 77,843 | $0.00 | $0.00 |
Footnotes (2)
- F1. On September 6, 2023, the Reporting Person was granted an award under the Issuer's 2022 Annual Long Term Incentive Plan (the "Plan"), which vests in the form of ordinary shares subject to (i) performance conditions, including a minimum return on equity underpin and growth in adjusted operating profit before tax, and (ii) continued service through the third anniversary of the grant date, in each case subject to the terms of the Plan. On August 19, 2026, the Remuneration Committee of the Issuer's Board of Directors determined that the performance conditions had been met. The award remains subject to time-based vesting and will fully vest on September 6, 2026.
- F2. The number of ordinary shares reported herein includes (i) 77,843 shares vesting under the Issuer's 2022 Annual Long Term Incentive Plan as described in footnote 1, and (ii) 194,411 shares underlying deferred bonus plan awards previously granted to the Reporting Person. Each award represents a contingent right to receive one (1) ordinary share of the Issuer upon vesting and settlement of the applicable award.
Key Figures
Key Terms
2022 Annual Long Term Incentive Plan financial
performance conditions financial
return on equity underpin financial
adjusted operating profit before tax financial
deferred bonus plan awards financial
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.
What insider transaction did MRX CEO Ian T. Lowitt report?
What performance conditions applied to the MRX long-term incentive award?
When did MRX determine that the performance conditions were met?
When will the MRX long-term incentive award fully vest for the CEO?
What other equity awards are included in the CEO’s MRX holdings?
AI-generated analysis. How Rhea-AI works. Not financial advice.